Exact Mass: 506.2718
Exact Mass Matches: 506.2718
Found 214 metabolites which its exact mass value is equals to given mass value 506.2718
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside]
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside]
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is found in tea. (3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is a constituent of leaves of Camellia sinensis var. sinensis (China tea). Constituent of leaves of Camellia sinensis variety sinensis (China tea). (3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is found in tea.
Ixabepilone
Ixabepilone is an epothilone B analog developed by Bristol-Myers Squibb as a cancer drug. On October 16, 2007, the U.S. Food and Drug Administration approved ixabepilone for the treatment of aggressive metastatic or locally advanced breast cancer no longer responding to currently available chemotherapies. Ixabepilone is administered through injection, and will be marketed under the trade name Ixempra. [Wikipedia] Ixabepilone is a semisynthetic analogue of epothilone B. It has a lactone lactam modification that
Abemaciclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(3R,9S)-megastigman-5-en-3,9-diol 3-O-[alpha-L-arabinofuranosyl-(1->6)]-beta-D-glucopyranoside
6beta-cinnamoyloxy-7beta-acetoxyvouacapen-5alpha-ol
7-megastigmen-3-ol-9-one 3-O-alpha-L-arabinofuranosyl-(1?6)-beta-D-glucopyranoside
(2R,9R)-megastigman-5-en-2,9-diol 9-O-alpha-L-arabinopyranosyl(1->6)-beta-D-glucopyranoside|foliasalacioside I
Phe Val Ile Glu
C30H38N2O5_(1E)-6-Hydroxy-12-(1H-indol-3-ylmethyl)-7-methoxy-4,13,13a-trimethyl-5,6,7,8,12,12a,13,13a,14a,14b-decahydro-3H-cycloundeca[d]oxireno[f]isoindole-9,10(4H,11H)-dione
C24H42O11_beta-D-Glucopyranoside, (1S,4R,5R)-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,3,5-trimethylcyclohexyl 6-O-[(2R,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]
Cys Lys Arg Thr
Cys Lys Thr Arg
Cys Arg Lys Thr
Cys Arg Thr Lys
Cys Thr Lys Arg
Cys Thr Arg Lys
Asp Phe Ile Ile
Asp Phe Ile Leu
Asp Phe Leu Ile
Asp Phe Leu Leu
Asp Ile Phe Ile
Asp Ile Phe Leu
Asp Ile Ile Phe
Asp Ile Leu Phe
Asp Leu Phe Ile
Asp Leu Phe Leu
Asp Leu Ile Phe
Asp Leu Leu Phe
Glu Phe Ile Val
Glu Phe Leu Val
Glu Phe Val Ile
Glu Phe Val Leu
Glu Ile Phe Val
Glu Ile Val Phe
Glu Leu Phe Val
Glu Leu Val Phe
Glu Val Phe Ile
Glu Val Phe Leu
Glu Val Ile Phe
Glu Val Leu Phe
Phe Asp Ile Ile
Phe Asp Ile Leu
Phe Asp Leu Ile
Phe Asp Leu Leu
Phe Glu Ile Val
Phe Glu Leu Val
Phe Glu Val Ile
Phe Glu Val Leu
Phe Ile Asp Ile
Phe Ile Asp Leu
Phe Ile Glu Val
Phe Ile Ile Asp
Phe Ile Leu Asp
Phe Ile Val Glu
Phe Leu Asp Ile
Phe Leu Asp Leu
Phe Leu Glu Val
Phe Leu Ile Asp
Phe Leu Leu Asp
Phe Leu Val Glu
Phe Val Glu Ile
Phe Val Glu Leu
Phe Val Leu Glu
Ile Asp Phe Ile
Ile Asp Phe Leu
Ile Asp Ile Phe
Ile Asp Leu Phe
Ile Glu Phe Val
Ile Glu Val Phe
Ile Phe Asp Ile
Ile Phe Asp Leu
Ile Phe Glu Val
Ile Phe Ile Asp
Ile Phe Leu Asp
Ile Phe Val Glu
Ile Ile Asp Phe
Ile Ile Phe Asp
Ile Leu Asp Phe
Ile Leu Phe Asp
Ile Val Glu Phe
Ile Val Phe Glu
Lys Cys Arg Thr
Lys Cys Thr Arg
Lys Arg Cys Thr
Lys Arg Thr Cys
Lys Thr Cys Arg
Lys Thr Arg Cys
Leu Asp Phe Ile
Leu Asp Phe Leu
Leu Asp Ile Phe
Leu Asp Leu Phe
Leu Glu Phe Val
Leu Glu Val Phe
Leu Phe Asp Ile
Leu Phe Asp Leu
Leu Phe Glu Val
Leu Phe Ile Asp
Leu Phe Leu Asp
Leu Phe Val Glu
Leu Ile Asp Phe
Leu Ile Phe Asp
Leu Leu Asp Phe
Leu Leu Phe Asp
Leu Val Glu Phe
Leu Val Phe Glu
Arg Cys Lys Thr
Arg Cys Thr Lys
Arg Lys Cys Thr
Arg Lys Thr Cys
Arg Thr Cys Lys
Arg Thr Lys Cys
Thr Cys Lys Arg
Thr Cys Arg Lys
Thr Lys Cys Arg
Thr Lys Arg Cys
Thr Arg Cys Lys
Thr Arg Lys Cys
Val Glu Phe Ile
Val Glu Phe Leu
Val Glu Ile Phe
Val Glu Leu Phe
Val Phe Glu Ile
Val Phe Glu Leu
Val Phe Ile Glu
Val Phe Leu Glu
Val Ile Glu Phe
Val Ile Phe Glu
Val Leu Glu Phe
Val Leu Phe Glu
(5Z,7E,22E)-(3S)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19),22-cholestatetraene-3,25-diol
Ixabepilone
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside]
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside]
(E)-12-((1H-indol-3-yl)methyl)-6-hydroxy-7-methoxy-4,13,13a-trimethyl-3,5,6,7,8,11,12,12a,13,13a,14a,14b-dodecahydro-9H-cycloundeca[d]oxireno[2,3-f]isoindole-9,10(4H)-dione
(22E)-26,26,26,27,27,27-hexafluoro-25-hydroxy-22,23-didehydrovitamin D3
Abemaciclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
1-Hexadecanoyl-2-(5-oxopentanoyl)-sn-glycero-3-phosphate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phospho-(1-sn-glycerol)
(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[1-(2-methyl-4-thiazolyl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione
3-{[(1r,9r,13e)-13-ethylidene-5-hydroxy-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-1-yl]amino}-3a,5-dihydroxy-6,8,8-trimethyl-3h,4h,5h,6h,6ah,7h,9h-azuleno[4,5-c]furan-1-one
(2s,3r,4s,5s,6r)-2-{[(1r)-4-[(3r)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}-6-({[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(2r)-4-[(1s)-1-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]butan-2-yl]oxy}oxane-3,4,5-triol
2-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[4-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl]oxy}oxane-3,4,5-triol
(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(1r)-4-[(3s)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}oxane-3,4,5-triol
(5s,7r,8r,10r,11r,12r,15r,16s,18z,25s)-11-acetyl-2,20-dihydroxy-10,26-dimethyl-21,26-diazapentacyclo[23.2.1.0⁵,¹⁶.0⁷,¹⁵.0⁸,¹²]octacosa-1,3,13,18,20-pentaene-27,28-dione
(2r,3r,4s,5r,6r)-2-({[(2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(2r)-4-[(4s)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]butan-2-yl]oxy}oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1s)-4-[(3r)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(3r,9s)-megastigman-5-en-3,9-diol-3-o-[α-l-arabinofuranosyl-(1→6)]-β-d-glucopyranoside
{"Ingredient_id": "HBIN009576","Ingredient_name": "(3r,9s)-megastigman-5-en-3,9-diol-3-o-[\u03b1-l-arabinofuranosyl-(1\u21926)]-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C24H42O11","Ingredient_Smile": "CC1=C(C(CC(C1)OC2C(C(C(C(O2)COC3C(C(C(O3)CO)O)O)O)O)O)(C)C)CCC(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13635","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}